OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
Aya Ozaki, Dennis T. Ko, Alice Chong, et al.
CMAJ Open (2023) Vol. 11, Iss. 3, pp. E494-E503
Open Access | Times Cited: 24
Aya Ozaki, Dennis T. Ko, Alice Chong, et al.
CMAJ Open (2023) Vol. 11, Iss. 3, pp. E494-E503
Open Access | Times Cited: 24
Showing 24 citing articles:
Prescription Patterns for Sodium-Glucose Cotransporter 2 Inhibitors in U.S. Health Systems
Jung‐Im Shin, Yunwen Xu, Alex R. Chang, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 8, pp. 683-693
Closed Access | Times Cited: 6
Jung‐Im Shin, Yunwen Xu, Alex R. Chang, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 8, pp. 683-693
Closed Access | Times Cited: 6
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Amanda Siriwardana, Luke Buizen, Min Jun, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Amanda Siriwardana, Luke Buizen, Min Jun, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies
Jiefu Lin, Xia Li, Yuhui Yang, et al.
Anesthesiology and Perioperative Science (2025) Vol. 3, Iss. 1
Open Access
Jiefu Lin, Xia Li, Yuhui Yang, et al.
Anesthesiology and Perioperative Science (2025) Vol. 3, Iss. 1
Open Access
Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART
Wade Thompson, B K Wong, Atul Sivaswamy, et al.
CJC Open (2025)
Open Access
Wade Thompson, B K Wong, Atul Sivaswamy, et al.
CJC Open (2025)
Open Access
The Effectiveness of an Electronic Decision Support Algorithm to Optimize Recommendations of SGLT2i and GLP-1RA in Patients with Type 2 Diabetes upon Discharge from Internal Medicine Wards
Irit Ayalon‐Dangur, E Jaffe, Alon Grossman, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2170-2170
Open Access
Irit Ayalon‐Dangur, E Jaffe, Alon Grossman, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2170-2170
Open Access
Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study
Ombretta Para, Marco Vanetti, Chiara Dibonaventura, et al.
Monaldi Archives for Chest Disease (2025)
Open Access
Ombretta Para, Marco Vanetti, Chiara Dibonaventura, et al.
Monaldi Archives for Chest Disease (2025)
Open Access
Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK , diabetes and kidney disease expert workshop
Zoe Markham‐Lee, Swati Bhagat‐Jones, Jill Carlton, et al.
Diabetic Medicine (2025)
Open Access
Zoe Markham‐Lee, Swati Bhagat‐Jones, Jill Carlton, et al.
Diabetic Medicine (2025)
Open Access
Optimisation of care among patients with diabetes mellitus and acute coronary syndrome through a specialised cardiodiabetes service—A registry study
Muhammad Usman Shah, Alun Roebuck, Bala Srinivasan, et al.
Diabetic Medicine (2025)
Open Access
Muhammad Usman Shah, Alun Roebuck, Bala Srinivasan, et al.
Diabetic Medicine (2025)
Open Access
Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022
Amy Yu, Peter C. Austin, Cynthia A. Jackevicius, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 3
Amy Yu, Peter C. Austin, Cynthia A. Jackevicius, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 3
Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort
Luke R. Gagnon, Deepan Hazra, Kevin Perera, et al.
American Heart Journal (2024) Vol. 274, pp. 11-22
Closed Access | Times Cited: 3
Luke R. Gagnon, Deepan Hazra, Kevin Perera, et al.
American Heart Journal (2024) Vol. 274, pp. 11-22
Closed Access | Times Cited: 3
Real-Time Use of SGLT2i Verified in Pre-dialysis: The RSVP Cross-sectional Study
Aylon Wisbaum, Sandrine Gaudreau, Isabelle Cloutier, et al.
Annals of Pharmacotherapy (2024) Vol. 59, Iss. 1, pp. 13-22
Open Access | Times Cited: 2
Aylon Wisbaum, Sandrine Gaudreau, Isabelle Cloutier, et al.
Annals of Pharmacotherapy (2024) Vol. 59, Iss. 1, pp. 13-22
Open Access | Times Cited: 2
Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real‐world settings: Insights from REVEAL ‐CKD
Navdeep Tangri, Christian S. Álvarez, Matthew Arnold, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 2
Navdeep Tangri, Christian S. Álvarez, Matthew Arnold, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 2
Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Dae Jung Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 837-846
Closed Access | Times Cited: 2
Ja Young Jeon, Dae Jung Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 837-846
Closed Access | Times Cited: 2
Global Kidney Health priorities – Perspectives from the ISN-GKHA
Ikechi G. Okpechi, Valérie A. Luyckx, Somkanya Tungsanga, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 11, pp. 1762-1771
Closed Access | Times Cited: 1
Ikechi G. Okpechi, Valérie A. Luyckx, Somkanya Tungsanga, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 11, pp. 1762-1771
Closed Access | Times Cited: 1
Prescription Patterns of Sodium-glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes and Heart Failure With Reduced Ejection Fracture Admitted to a Tertiary Care Centre in Ontario, Canada
Alaa Mohamed, Erin Keely, Kylie McNeill, et al.
Canadian Journal of Diabetes (2024) Vol. 48, Iss. 7, pp. 439-445.e1
Open Access | Times Cited: 1
Alaa Mohamed, Erin Keely, Kylie McNeill, et al.
Canadian Journal of Diabetes (2024) Vol. 48, Iss. 7, pp. 439-445.e1
Open Access | Times Cited: 1
Rhabdomyolysis and Sodium-Glucose–Linked Transport Inhibitors in Patients Taking Statins
Ziv Harel, Nivethika Jeyakumar, Graham Smith, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2446641-e2446641
Open Access | Times Cited: 1
Ziv Harel, Nivethika Jeyakumar, Graham Smith, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2446641-e2446641
Open Access | Times Cited: 1
Acetazolamide Tolerance in Acute Decompensated Heart Failure: An Observational Study
I Mercado, Sophie Putot, Elena Fertu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3421-3421
Open Access | Times Cited: 1
I Mercado, Sophie Putot, Elena Fertu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3421-3421
Open Access | Times Cited: 1
Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021
Taufiq Salahuddin, Annika Hebbe, Marguerite Daus, et al.
American Heart Journal (2023) Vol. 268, pp. 68-79
Closed Access | Times Cited: 2
Taufiq Salahuddin, Annika Hebbe, Marguerite Daus, et al.
American Heart Journal (2023) Vol. 268, pp. 68-79
Closed Access | Times Cited: 2
Expanding Indications for the Sodium-Cotransporter Glucose 2 Inhibitors Application in Type 2 Diabetes Mellitus
Т. В. Мохорт
Рецепт (2024) Vol. 27, Iss. 2, pp. 214-231
Open Access
Т. В. Мохорт
Рецепт (2024) Vol. 27, Iss. 2, pp. 214-231
Open Access
Prescribing Patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Patients with T2DM and ASCVD in South Korea
Yeong Rok Eom, Hajung Joo, Seung Eun Chae, et al.
Research Square (Research Square) (2024)
Open Access
Yeong Rok Eom, Hajung Joo, Seung Eun Chae, et al.
Research Square (Research Square) (2024)
Open Access
efficacy and safety of dapagliflozin in patients with ckd: Real world experience in 93 italian renal clinics
Roberto Minutolo, Silvio Borrelli, A Ambrosini, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 1
Open Access
Roberto Minutolo, Silvio Borrelli, A Ambrosini, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 1
Open Access
Long‐term benefit of SGLT2 inhibitors to prevent heart failure hospitalization in patients with diabetes, with potential time‐varying benefit
Yasuo Takahashi, Kimino Minagawa, Takuya Nagashima, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
Yasuo Takahashi, Kimino Minagawa, Takuya Nagashima, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
